Cargando…

Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand

OBJECTIVE: To identify predictors of faster time to virological suppression among infants starting combination antiretroviral therapy (cART) early in infancy. DESIGN: Cohort study of infants from Europe and Thailand included in studies participating in the European Pregnancy and Paediatric HIV Cohor...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511423/ https://www.ncbi.nlm.nih.gov/pubmed/30741823 http://dx.doi.org/10.1097/QAD.0000000000002172

Ejemplares similares

Time to Viral Suppression in Perinatally HIV-Infected Infants Depends on the Viral Load and CD4 T-Cell Percentage at the Start of Treatment
por: Schröter, Juliane, et al.
Publicado: (2020)

Quantification of CD4 Recovery in Early-Treated Infants Living With HIV
por: Schröter, Juliane, et al.
Publicado: (2022)

Alcohol use, suicidality and virologic non‐suppression among young adults with perinatally acquired HIV in Thailand: a cross‐sectional study
por: Aurpibul, Linda, et al.
Publicado: (2023)

CD4(+) and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States
por: Fairlie, Lee, et al.
Publicado: (2015)

Normal structural brain development in adolescents treated for perinatally acquired HIV: a longitudinal imaging study
por: Van den Hof, Malon, et al.
Publicado: (2021)

Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study
por: van Lunzen, Jan, et al.
Publicado: (2016)

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
por: Gras, Luuk, et al.
Publicado: (2019)

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study
por: Gori, Andrea, et al.
Publicado: (2020)

Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial
por: Kumar, Princy, et al.
Publicado: (2021)

Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States
por: Elbur, Abubaker Ibrahim, et al.
Publicado: (2023)

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults
por: Raffi, François, et al.
Publicado: (2017)

Platelet Count in First Trimester of Pregnancy as a Predictor of Perinatal Outcome
por: Larroca, Santiago Garcia-Tizon, et al.
Publicado: (2017)

Brief Report: Improving Early Infant Diagnosis Observations: Estimates of Timely HIV Testing and Mortality Among HIV-Exposed Infants
por: Webb, Karen, et al.
Publicado: (2020)

Pregnancy Outcomes Among Perinatally HIV-Infected Women in Spain
por: Nogueira López, Javier, et al.
Publicado: (2022)

Higher rates of triple‐class virological failure in perinatally HIV‐infected teenagers compared with heterosexually infected young adults in Europe
por: Judd, A, et al.
Publicado: (2016)

Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children
por: Bienczak, Andrzej, et al.
Publicado: (2016)

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial
por: Johnson, Margaret, et al.
Publicado: (2019)

Sustained Virologic Suppression Reduces HIV-1 DNA Proviral Levels and HIV Antibodies in Perinatally HIV-Infected Children Followed from Birth
por: Fuller, Trevon, et al.
Publicado: (2022)

Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand
por: Putcharoen, Opass, et al.
Publicado: (2019)

Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
por: Ateba Ndongo, Francis, et al.
Publicado: (2015)

Cryptococcal Antigen Screening and Missed Opportunities for Earlier Diagnosis Among People With HIV and Poor Virologic Control in the Bronx, NY
por: Yoon, Hyunah, et al.
Publicado: (2022)

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis
por: Cutrell, Amy G., et al.
Publicado: (2021)

The Clinical Impact and Cost-Effectiveness of Clinic-Based Cognitive Behavioral Therapy for People With HIV, Depression, and Virologic Failure in South Africa
por: Gandhi, Aditya R., et al.
Publicado: (2023)

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi‐centre 48‐week efficacy and safety study in Thailand
por: Phongsamart, Wanatpreeya, et al.
Publicado: (2022)

Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in Thailand
por: Chintanaphol, Michelle, et al.
Publicado: (2018)

Brief Report: Safety of Frequent Blood Sampling in Research Participants in an Acute HIV Infection Cohort in Thailand
por: Sacdalan, Carlo, et al.
Publicado: (2017)

Viral Response among Early Treated HIV Perinatally Infected Infants: Description of a Cohort in Southern Mozambique
por: Lain, Maria Grazia, et al.
Publicado: (2022)

Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
por: Dow, Dorothy E, et al.
Publicado: (2014)

Early Adherence to Antiretroviral Medication as a Predictor of Long-Term HIV Virological Suppression: Five-Year Follow Up of an Observational Cohort
por: Ford, Nathan, et al.
Publicado: (2010)

Predicting, Diagnosing, and Treating Acute and Early HIV Infection in a Public Sector Facility in Eswatini
por: Kerschberger, Bernhard, et al.
Publicado: (2021)

Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection
por: Rossetti, Barbara, et al.
Publicado: (2021)

Pregnancies in perinatally HIV-infected women: antiretroviral treatment strategies, obstetric and virologic outcomes
por: Cecchini, Diego, et al.
Publicado: (2018)

Adoption is not associated with immunological and virological outcomes in children with perinatally acquired HIV infection in the Netherlands
por: Van Den Hof, Malon, et al.
Publicado: (2023)

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment
por: Pantazis, Nikos, et al.
Publicado: (2016)

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland
por: Duong, Trinh, et al.
Publicado: (2014)

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa
por: Kityo, Cissy, et al.
Publicado: (2017)

Analysis of HIV Early Infant Diagnosis Data to Estimate Rates of Perinatal HIV Transmission in Zambia
por: Torpey, Kwasi, et al.
Publicado: (2012)

Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children
por: Domínguez-Rodríguez, Sara, et al.
Publicado: (2022)

Brief Report: Virologic Impact of the Dolutegravir Transition: Prospective Results From the Multinational African Cohort Study
por: Esber, Allahna, et al.
Publicado: (2022)

Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1qmr6rh2adim113n5c0u6kf94l